Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2012 1
2013 1
2014 1
2016 1
2017 1
2019 3
2020 2
2021 1
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean blankenberg s and indicate (74 results)?
Transcatheter or Surgical Treatment of Aortic-Valve Stenosis.
Blankenberg S, Seiffert M, Vonthein R, Baumgartner H, Bleiziffer S, Borger MA, Choi YH, Clemmensen P, Cremer J, Czerny M, Diercks N, Eitel I, Ensminger S, Frank D, Frey N, Hagendorff A, Hagl C, Hamm C, Kappert U, Karck M, Kim WK, König IR, Krane M, Landmesser U, Linke A, Maier LS, Massberg S, Neumann FJ, Reichenspurner H, Rudolph TK, Schmid C, Thiele H, Twerenbold R, Walther T, Westermann D, Xhepa E, Ziegler A, Falk V; DEDICATE-DZHK6 Trial Investigators. Blankenberg S, et al. N Engl J Med. 2024 Apr 8. doi: 10.1056/NEJMoa2400685. Online ahead of print. N Engl J Med. 2024. PMID: 38588025
(Funded by the German Center for Cardiovascular Research and the German Heart Foundation; DEDICATE-DZHK6 ClinicalTrials.gov number, NCT03112980.)....
(Funded by the German Center for Cardiovascular Research and the German Heart Foundation; DEDICATE-DZHK6 ClinicalTrials.gov number, N …
Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients at low to intermediate surgical risk: rationale and design of the randomised DEDICATE Trial.
Seiffert M, Vonthein R, Baumgartner H, Borger MA, Choi YH, Falk V, Frey N, Hagendorff A, Hagl C, Hamm C, König IR, Landmesser U, Massberg S, Reichenspurner H, Thiele H, Twerenbold R, Vens M, Walther T, Ziegler A, Cremer J, Blankenberg S. Seiffert M, et al. EuroIntervention. 2023 Oct 23;19(8):652-658. doi: 10.4244/EIJ-D-23-00232. EuroIntervention. 2023. PMID: 37655862 Free article.
However, in younger, low-risk patients for whom both therapeutic options, TAVI and SAVR, are applicable, the optimal treatment strategy remains controversial, as data on long-term outcomes remain limited. The DEDICATE-DZHK6 Trial is an investigator-initiated, industry-inde …
However, in younger, low-risk patients for whom both therapeutic options, TAVI and SAVR, are applicable, the optimal treatment strategy rema …
Clinical outcomes of transcatheter mitral valve replacement: two-year results of the CHOICE-MI Registry.
Ludwig S, Perrin N, Coisne A, Ben Ali W, Weimann J, Duncan A, Akodad M, Scotti A, Kalbacher D, Bleiziffer S, Nickenig G, Hausleiter J, Ruge H, Adam M, Petronio AS, Dumonteil N, Sondergaard L, Adamo M, Regazzoli D, Garatti A, Schmidt T, Dahle G, Taramasso M, Walther T, Kempfert J, Obadia JF, Chehab O, Tang GHL, Latib A, Goel SS, Fam NP, Andreas M, Muller DW, Denti P, Praz F, von Bardeleben RS, Granada JF, Modine T, Conradi L; Collaborators. Ludwig S, et al. EuroIntervention. 2023 Aug 21;19(6):512-525. doi: 10.4244/EIJ-D-22-01037. EuroIntervention. 2023. PMID: 37235388 Free article.
BACKGROUND: Transcatheter mitral valve replacement (TMVR) using dedicated devices is an alternative therapy for high-risk patients with symptomatic mitral regurgitation (MR). ...METHODS: The CHOICE-MI Registry included consecutive patients with symptomatic MR treated with …
BACKGROUND: Transcatheter mitral valve replacement (TMVR) using dedicated devices is an alternative therapy for high-risk patients wi …
The DEDICATE Trial: An independent all-comers trial of transcatheter aortic valve implantation vs. surgical aortic valve replacement in patients at low to intermediate operative risk is recruiting patients.
Seiffert M, Walther T, Hamm C, Falk V, Frey N, Thiele H, Hagl C, Landmesser U, Borger M, Massberg S, Reichenspurner H, Baumgartner H, Blankenberg S, Cremer J. Seiffert M, et al. Eur Heart J. 2019 Jan 21;40(4):331-333. doi: 10.1093/eurheartj/ehy851. Eur Heart J. 2019. PMID: 30668699 Review. No abstract available.
Rationale and Design of the Hamburg City Health Study.
Jagodzinski A, Johansen C, Koch-Gromus U, Aarabi G, Adam G, Anders S, Augustin M, der Kellen RB, Beikler T, Behrendt CA, Betz CS, Bokemeyer C, Borof K, Briken P, Busch CJ, Büchel C, Brassen S, Debus ES, Eggers L, Fiehler J, Gallinat J, Gellißen S, Gerloff C, Girdauskas E, Gosau M, Graefen M, Härter M, Harth V, Heidemann C, Heydecke G, Huber TB, Hussein Y, Kampf MO, von dem Knesebeck O, Konnopka A, König HH, Kromer R, Kubisch C, Kühn S, Loges S, Löwe B, Lund G, Meyer C, Nagel L, Nienhaus A, Pantel K, Petersen E, Püschel K, Reichenspurner H, Sauter G, Scherer M, Scherschel K, Schiffner U, Schnabel RB, Schulz H, Smeets R, Sokalskis V, Spitzer MS, Terschüren C, Thederan I, Thoma T, Thomalla G, Waschki B, Wegscheider K, Wenzel JP, Wiese S, Zyriax BC, Zeller T, Blankenberg S. Jagodzinski A, et al. Eur J Epidemiol. 2020 Feb;35(2):169-181. doi: 10.1007/s10654-019-00577-4. Epub 2019 Nov 8. Eur J Epidemiol. 2020. PMID: 31705407 Free PMC article.
A random sample of 45,000 participants between 45 and 74 years of age from the general population of Hamburg, Germany, are taking part in an extensive baseline assessment at one dedicated study center. Participants undergo 13 validated and 5 novel examinations primarily ta …
A random sample of 45,000 participants between 45 and 74 years of age from the general population of Hamburg, Germany, are taking part in an …
Characteristics and outcomes of patients screened for transcatheter mitral valve implantation: 1-year results from the CHOICE-MI registry.
Ben Ali W, Ludwig S, Duncan A, Weimann J, Nickenig G, Tanaka T, Coisne A, Vincentelli A, Makkar R, Webb JG, Akodad M, Muller DWM, Praz F, Wild MG, Hausleiter J, Goel SS, von Ballmoos MW, Denti P, Chehab O, Redwood S, Dahle G, Baldus S, Adam M, Ruge H, Lange R, Kaneko T, Leroux L, Dumonteil N, Tchetche D, Treede H, Flagiello M, Obadia JF, Walther T, Taramasso M, Søndergaard L, Bleiziffer S, Rudolph TK, Fam N, Kempfert J, Granada JF, Tang GHL, von Bardeleben RS, Conradi L, Modine T; CHOICE-MI Investigators. Ben Ali W, et al. Eur J Heart Fail. 2022 May;24(5):887-898. doi: 10.1002/ejhf.2492. Epub 2022 Apr 17. Eur J Heart Fail. 2022. PMID: 35338542 Free article.
Among 746 patients included (78.5 years, interquartile range [IQR] 72.0-83.0, EuroSCORE II 4.7% [IQR 2.7-9.7]), 229 patients (30.7%) underwent TMVI with 10 different dedicated devices. At 1 year, residual MR 1+ was present in 95.2% and the primary endpoint occurred in 39.2 …
Among 746 patients included (78.5 years, interquartile range [IQR] 72.0-83.0, EuroSCORE II 4.7% [IQR 2.7-9.7]), 229 patients (30.7%) underwe …
Early results of a real-world series with two transapical transcatheter mitral valve replacement devices.
Ludwig S, Kalbacher D, Schofer N, Schäfer A, Koell B, Seiffert M, Schirmer J, Schäfer U, Westermann D, Reichenspurner H, Blankenberg S, Lubos E, Conradi L. Ludwig S, et al. Clin Res Cardiol. 2021 Mar;110(3):411-420. doi: 10.1007/s00392-020-01757-z. Epub 2020 Oct 19. Clin Res Cardiol. 2021. PMID: 33074368 Free PMC article.
AIMS: Transcatheter mitral valve replacement (TMVR) with dedicated devices promises to fill the treatment gap between open-heart surgery and edge-to-edge repair for patients with severe mitral regurgitation (MR). ...
AIMS: Transcatheter mitral valve replacement (TMVR) with dedicated devices promises to fill the treatment gap between open-heart surg …
Heart failure in the general population and impact of the 2021 European Society of Cardiology Heart Failure Guidelines.
Wenzel JP, Nikorowitsch J, Bei der Kellen R, Magnussen C, Bonin-Schnabel R, Westermann D, Twerenbold R, Kirchhof P, Blankenberg S, Schrage B. Wenzel JP, et al. ESC Heart Fail. 2022 Aug;9(4):2157-2169. doi: 10.1002/ehf2.13948. Epub 2022 Apr 20. ESC Heart Fail. 2022. PMID: 35445582 Free PMC article.
Although four drugs are recommended for all subjects with HFrEF in the new guidelines, several adjunctive therapies are recommended for dedicated cases/scenarios (e.g. <1% eligibility for ivabradine/vericiguat/devices). ...
Although four drugs are recommended for all subjects with HFrEF in the new guidelines, several adjunctive therapies are recommended for d …
T1 mapping cardiovascular magnetic resonance imaging to detect myocarditis-Impact of slice orientation on the diagnostic performance.
Bohnen S, Radunski UK, Lund GK, Tahir E, Avanesov M, Stehning C, Schnackenburg B, Adam G, Blankenberg S, Muellerleile K. Bohnen S, et al. Eur J Radiol. 2017 Jan;86:6-12. doi: 10.1016/j.ejrad.2016.10.031. Epub 2016 Oct 31. Eur J Radiol. 2017. PMID: 28027767
Native T1, post-contrast T1 and extracellular volume (ECV) -BOPTA maps were calculated using a dedicated plug-in written for the OsiriX software and compared between the mean value of three short-axes slices (3SAX), the central short-axis (1SAX), the mean value of three lo …
Native T1, post-contrast T1 and extracellular volume (ECV) -BOPTA maps were calculated using a dedicated plug-in written for the Osir …
Prosthesis-patient mismatch after transcatheter aortic valve implantation: prevalence and prognostic impact with respect to baseline left ventricular function.
Schofer N, Deuschl F, Rübsamen N, Skibowski J, Seiffert M, Voigtländer L, Schaefer A, Schneeberger Y, Schirmer J, Reichenspurner H, Blankenberg S, Conradi L, Schäfer U. Schofer N, et al. EuroIntervention. 2019 Mar 20;14(16):1648-1655. doi: 10.4244/EIJ-D-18-00827. EuroIntervention. 2019. PMID: 30418159 Free article.
METHODS AND RESULTS: Data from 1,309 patients undergoing TAVI for severe aortic stenosis were derived from a single-centre dedicated TAVI registry. PPM was assessed according to echocardiography at discharge and was defined in accordance with VARC-2. ...
METHODS AND RESULTS: Data from 1,309 patients undergoing TAVI for severe aortic stenosis were derived from a single-centre dedicated …
13 results